Innoviva, Inc.
(NASDAQ : INVA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corporation Plc Sponsored ADR
-2.34%19.192.0%$602.02m
SHPGShire PLC Sponsored ADR
1.05%172.190.4%$144.03m
GWPHGW Pharmaceuticals PLC Sponsored ADR
0.80%144.476.8%$132.86m
PRGOPerrigo Co. Plc
2.44%71.876.8%$92.98m
JAZZJazz Pharmaceuticals Plc
-1.15%157.002.2%$64.37m
ENDPEndo International Plc
0.89%17.678.9%$59.53m
MNKMallinckrodt Plc
0.59%27.3221.1%$58.14m
SAGESAGE Therapeutics, Inc.
-2.74%121.409.6%$46.68m
ICPTIntercept Pharmaceuticals, Inc.
-2.78%100.8518.7%$46.32m
UTHRUnited Therapeutics Corporation
0.98%124.3214.4%$35.25m
CTLTCatalent Inc
0.60%41.722.4%$32.57m
ICLRICON Plc
-0.54%144.144.1%$31.63m
PCRXPacira Pharmaceuticals, Inc.
2.70%45.3310.6%$25.75m
AERIAerie Pharmaceuticals, Inc.
0.89%55.866.9%$25.44m
MDCOMedicines Company
1.91%26.7321.8%$25.29m

Company Profile

Innoviva, Inc. engages in the development, commercialization, and financial management of bio-pharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate; and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI. The company was founded by P. Roy Vagelos, Mathai Mammen, and George M. Whitesides in November 1996 and is headquartered in Brisbane, CA.